SweetDeep: A Wearable AI Solution for Real-Time Non-Invasive Diabetes Screening

Fuente: arXiv
Saved in:
Bibliographic Details
Main Authors: Henriques, Ian, Elhassar, Lynda, Relekar, Sarvesh, Walrave, Denis, Hassantabar, Shayan, Ghanakota, Vishu, Laoui, Adel, Aich, Mahmoud, Tir, Rafia, Zerguine, Mohamed, Louafi, Samir, Kimouche, Moncef, Cosson, Emmanuel, Jha, Niraj K
Format: Preprint
Published: 2025
Subjects:
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1866914184753577984
author Henriques, Ian
Elhassar, Lynda
Relekar, Sarvesh
Walrave, Denis
Hassantabar, Shayan
Ghanakota, Vishu
Laoui, Adel
Aich, Mahmoud
Tir, Rafia
Zerguine, Mohamed
Louafi, Samir
Kimouche, Moncef
Cosson, Emmanuel
Jha, Niraj K
author_facet Henriques, Ian
Elhassar, Lynda
Relekar, Sarvesh
Walrave, Denis
Hassantabar, Shayan
Ghanakota, Vishu
Laoui, Adel
Aich, Mahmoud
Tir, Rafia
Zerguine, Mohamed
Louafi, Samir
Kimouche, Moncef
Cosson, Emmanuel
Jha, Niraj K
contents The global rise in type 2 diabetes underscores the need for scalable and cost-effective screening methods. Current diagnosis requires biochemical assays, which are invasive and costly. Advances in consumer wearables have enabled early explorations of machine learning-based disease detection, but prior studies were limited to controlled settings. We present SweetDeep, a compact neural network trained on physiological and demographic data from 285 (diabetic and non-diabetic) participants in the EU and MENA regions, collected using Samsung Galaxy Watch 7 devices in free-living conditions over six days. Each participant contributed multiple 2-minute sensor recordings per day, totaling approximately 20 recordings per individual. Despite comprising fewer than 3,000 parameters, SweetDeep achieves 82.5% patient-level accuracy (82.1% macro-F1, 79.7% sensitivity, 84.6% specificity) under three-fold cross-validation, with an expected calibration error of 5.5%. Allowing the model to abstain on less than 10% of low-confidence patient predictions yields an accuracy of 84.5% on the remaining patients. These findings demonstrate that combining engineered features with lightweight architectures can support accurate, rapid, and generalizable detection of type 2 diabetes in real-world wearable settings.
format Preprint
id arxiv_https___arxiv_org_abs_2512_03471
institution arXiv
publishDate 2025
record_format arxiv
spellingShingle SweetDeep: A Wearable AI Solution for Real-Time Non-Invasive Diabetes Screening
Henriques, Ian
Elhassar, Lynda
Relekar, Sarvesh
Walrave, Denis
Hassantabar, Shayan
Ghanakota, Vishu
Laoui, Adel
Aich, Mahmoud
Tir, Rafia
Zerguine, Mohamed
Louafi, Samir
Kimouche, Moncef
Cosson, Emmanuel
Jha, Niraj K
Machine Learning
Computers and Society
The global rise in type 2 diabetes underscores the need for scalable and cost-effective screening methods. Current diagnosis requires biochemical assays, which are invasive and costly. Advances in consumer wearables have enabled early explorations of machine learning-based disease detection, but prior studies were limited to controlled settings. We present SweetDeep, a compact neural network trained on physiological and demographic data from 285 (diabetic and non-diabetic) participants in the EU and MENA regions, collected using Samsung Galaxy Watch 7 devices in free-living conditions over six days. Each participant contributed multiple 2-minute sensor recordings per day, totaling approximately 20 recordings per individual. Despite comprising fewer than 3,000 parameters, SweetDeep achieves 82.5% patient-level accuracy (82.1% macro-F1, 79.7% sensitivity, 84.6% specificity) under three-fold cross-validation, with an expected calibration error of 5.5%. Allowing the model to abstain on less than 10% of low-confidence patient predictions yields an accuracy of 84.5% on the remaining patients. These findings demonstrate that combining engineered features with lightweight architectures can support accurate, rapid, and generalizable detection of type 2 diabetes in real-world wearable settings.
title SweetDeep: A Wearable AI Solution for Real-Time Non-Invasive Diabetes Screening
topic Machine Learning
Computers and Society
url https://arxiv.org/abs/2512.03471